Video

Jeremy Orr, MD, MPH: Mistakes with AI During COVID-19

How the US has misused AI during the pandemic and the state of the country without the technology.

Jeremy Orr, MD, MPH

Jeremy Orr, MD, MPH

Along with challenges of leveraging artificial intelligence (AI) during the coronavirus disease 2019 (COVID-19) pandemic, many mistakes have been made as well.

Physicians and health systems need to learn how to properly use the technology to be prepared for future pandemics.

Two areas for improvement lie in surveillance and resource allocation, Jeremy Orr, MD, MPH, chief executive officer of Medial EarlySign, said in a recent interview with HCPLive®.

“No doubt we’re going to do better the next time around and more of these technologies will be deployed and used properly,” Orr said.

Public health officials from the top like the Centers for Disease Control and Prevention (CDC) to the bottom like state departments were heroic in their efforts but fell short amid challenges.

This is also a critical learning period in terms of racial disparity, he said. Machine-learning algorithms and AI, if not carefully designed and tested, could exacerbate the biases and effects seen in data.

“We have to be extremely mindful of biases in data and then how these algorithms are delivered and make sure they are not contributing to inequality of care delivery and other factors,” he said.

Still, without AI, society would likely be worse off.

To hear more from Orr, watch the clip below.

Related Videos
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Julia Moore Vogel, PhD, MBA: How Do We Define Long Covid Patients?
© 2024 MJH Life Sciences

All rights reserved.